Candida peritonitis

Fungal Peritonitis in Patients on Continuous Ambulatory Peritoneal Dialysis

“…[ll],and I case out of 10 in the series by Bayer et al [2]. During the course of a bacterial peritonitis with CAPD, the absence of fever, leukocytosis (blood), or bacteremia has been noted [6].…”

“…The disadvan tages consist in having to remove and replace the cathe ter, which weakens the abdominal wall, and increases the stress and discomfort to the patient. Fungal peritonitis often recovers in patients treated with intermittent perito neal dialysis without removing the catheter [2,3,7,14]. In the series of Bayeret al [2] of 10 cases of fungal peritoni tis, 4 recovered with only peritoneal lavage, 2 recovered with peritoneal lavage associated with local and systemic antifungal therapy, and 3 recovered after removal of the catheter.…”

Peritoneal Dialysis Complicated by <i>Aspergillus flavus</i> Peritonitis: A Role for Fungal Antigen Serodiagnosis

“…Most commonly, it results from bacterial contamination of the peritoneum, although in 25% of patients no organism can be isolated [2], Recently, fungal infectious complications have been recognized in this group [1,[3][4][5][6][7][8][9]. Of the 22 patients with candidal peritonitis de scribed by Bayer etal.…”

“…Of the 22 patients with candidal peritonitis de scribed by Bayer etal. [3], lOdeveloped the infection second ary to peritoneal dialysis. Recently, Arafani et al [I] de scribed 3 patients with candidal and a fourth with aspergillus peritonitis which complicated chronic ambulatory peritoneal dialysis.…”

Experimental Intraabdominal Candidiasis: Macroscopic, Microscopic and Cultural Natural History

“…Intraabdominal candi diasis, a disorder rarely reported prior to 1960, is now being recognized with increasing fre quency, especially as a complication of peri toneal dialysis, gastrointestinal surgery, or per foration of an abdominal viscus (5). We have developed a rabbit model for this disease to 1 Presented in part at the 17th Interscience Confer ence on Antimicrobial Agents and Chemotherapy, New York, October 13.…”